Despite having 10-12 hypos per month, Scott Bissinger had a problem remembering to carry fast-acting glucose with him. The reason? Lack of what he calls “the portability of glucose.” He knew there had to be a better way, and his proposed solution to the problem won him second place (and $10,000!) in a business venture competition at the University of North Carolina at Chapel Hill, where he was a senior majoring in Business Administration with…Read more »
Continuing our series of interviews with the 10 winners of the DiabetesMine Patient Voices Contest that were announced in June, today we’re featuring none other than long-time diabetes blogger and advocate, Sara “Knicks” Nicastro, who was diagnosed with type 1 diabetes at age 21. Sara lives in Florida and works in higher education administration.
In her contest video, Sara discussed her thoughts on device personalization, like what’s offered by many smartphone apps these days. We…Read more »
Bye bye, oval-shaped Dexcom Seven Plus continuous glucose monitor!
Hello, next generation Dexcom G4 Platinum CGM that’s sleeker, more accurate and for sure looks more like an iPhone than a medical device (!)
Today, San Diego, CA-based Dexcom issued a news release announcing that its much-anticipated Dexcom G4 (generation 4) Platinum device has received FDA approval.
Here is the FDA approval letter, and a regulatory agency overview of the approval.
Along with the rest of…
One particular moment doesn’t stand out about the MedicineX conference at Stanford University this past week. Instead, it was all of the moments!
What I keep coming back to in my mind is the recurring theme of this event: that the voice of the patient is incredibly meaningful, and should be a part of the healthcare process, from beginning to end.
That, IMHO, is was what the three-day MedX conference was all about. A few…
Those of us in the U.S. sometimes feel as though our Diabetes Community friends across the pond get all the coolest gadgets and medications before we do Stateside.
A preview of highlights at this year’s big diabetes shindig, the Annual Meeting of the European Association for the Study of Diabetes (EASD), reinforced that feeling but brings a whole lot of excitement, since we are getting a glimpse into the future of what’s to come.